MYGN icon

Myriad Genetics

221 hedge funds and large institutions have $2.23B invested in Myriad Genetics in 2019 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 71 increasing their positions, 79 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

less funds holding

Funds holding:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

16% less call options, than puts

Call options by funds: $11.7M | Put options by funds: $13.8M

29% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 45

Holders
221
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$11.7M
Puts
$13.8M
Net Calls
Net Calls Change

Top Sellers

1 -$47.7M
2 -$35M
3 -$24.2M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$23.5M
5
State Street
State Street
Massachusetts
-$15.7M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$4.92M
52
$4.88M
53
$4.55M
54
$4.06M
55
$4.06M
56
$4.02M
57
$3.95M
58
$3.94M
59
$3.75M
60
$3.71M
61
$3.58M
62
$3.36M
63
$3.14M
64
$3.03M
65
$3.01M
66
$2.73M
67
$2.65M
68
$2.56M
69
$2.48M
70
$2.31M
71
$2.29M
72
$2.08M
73
$1.99M
74
$1.88M
75
$1.85M